The 20 Best Inflammatory Breast Cancer Doctors Near Me in Teaneck, NJ

Donna Mcnamara is an Oncologist practicing medicine in Hackensack, New Jersey. Dr. Mcnamara is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Inflammatory Breast Cancer, Breast Cancer, and Angiosarcoma.

Deena Graham is an Oncologist practicing medicine in Hackensack, New Jersey. Dr. Graham is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. She is also highly rated in 23 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, and Gastrostomy. Dr. Graham is board certified in American Board Of Internal Medicine.

Stanley Waintraub is an Oncologist practicing medicine in Hackensack, New Jersey. Dr. Waintraub is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer. Dr. Waintraub is board certified in American Board Of Internal Medicine and Hematology.

Massimo Cristofanilli is an Oncologist practicing medicine in New York, New York. Dr. Cristofanilli is rated as an Elite provider by MediFind in the treatment of Inflammatory Breast Cancer. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, PIK3CA-Related Overgrowth Spectrum, Triple-Negative Breast Cancer, and Tissue Biopsy. Dr. Cristofanilli is currently accepting new patients.

Dr. Hershman is Witten Family Professor of Medicine, American Cancer Society Professor of Medicine and Epidemiology, chief of the division of hematology/oncology, and deputy director of the Herbert Irving Comprehensive Cancer Center at Columbia University. She completed her medical degree at the Albert Einstein College of Medicine, and completed her internal medicine and oncology fellowship training at Columbia University Medical Center, where she served as Chief Resident. During that time she completed a Master's degree in Biostatistics at the Mailman School of Public Health. She has developed nationally recognized expertise in breast cancer treatment, prevention, and survivorship.Dr. Hershman has also developed a comprehensive multidisciplinary program to study ways of improving cancer care delivery (CCD), reducing disparities and designing studies to improve the quality of life and quality of care in breast cancer survivors. She has received funding from the American Society of Clinical Oncology, American Cancer Society, Department of Defense, Breast Cancer Research Foundation, PCORI, and the National Cancer Institute. She currently has mentored numerous faculty members who have been granted mentored career development awards, and has received the Women Who Conquer Cancer Mentorship Award and the CUIMC Mentor of the Year Award. Dr. Hershman has published over 450 scientific articles and has received several awards including the highly prestigious Advanced Clinical Research Award in Breast Cancer from the American Society of Clinical Oncology, the Advanced Medical Achievement Award from the Avon Foundation and a Giants in Cancer Care Award.She has several national leadership roles in oncology. As vice chair of the SWOG Cancer Research Network she oversees the NCI's Community Oncology Research Programs (NCORP) research portfolio, which includes prevention and epidemiology, cancer care delivery, symptom control and quality of life, and survivorship trials. Within ASCO she was selected to participate in the first Leadership Development Program and has been the Chair of the Grants Selection Committee, Chair of the ASCO Quality Care Symposium and has been a member of multiple committees and task-forces. She is on the editorial board for the Journal of Clinical Oncology and is an Associate Editor at the Journal of the National Cancer Institute. Dr. Hershman is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Febrile Neutropenia, Inflammatory Breast Cancer, Vulvectomy, and Salpingo-Oophorectomy. Dr. Hershman is board certified in Internal Medicine and Medical Oncology. Dr. Hershman is currently accepting new patients.

Katherine D. Crew, M.D., M.S. is an the Avon Products Foundation Professor of Medicine and Epidemiology at the NewYork-Presbyterian/Columbia University Medical Center, co-associate director for education and training and co-director of the Cancer Research Training and Education Core (CRTEC) at the Herbert Irving Comprehensive Cancer Center (HICCC). In addition to treating patients with breast cancer and women at high-risk for breast cancer, Dr. Crew has a long-standing interest and background in the design of clinical trials and observational studies in breast cancer prevention and survivorship.She serves as the Director of the Clinical Breast Cancer Prevention Program at Columbia University and Executive Officer for the SWOG Prevention, Screening, and Surveillance and Cancer Care Delivery Committees. She is a member of multiple national consortia and societies in oncology, including the American Association for Cancer Research and American Society of Clinical Oncology, and is an editorial board member of the Journal of Clinical Oncology. Dr. Crew received her undergraduate B.S. in Biochemistry from Brown University, where she graduated Magna Cum Laude. She received her M.D. from Columbia University College of Physicians and Surgeons and her M.S. from Columbia University School of Public Health. She completed her Internal Medicine residency and Medical Oncology fellowship at NewYork-Presbyterian/Columbia University Medical Center. Dr. Crew is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Salpingo-Oophorectomy. Dr. Crew is board certified in Internal Medicine and Medical Oncology. Dr. Crew is currently accepting new patients.

Lisa Wiechmann is a General Surgeon practicing medicine in New York, New York. Dr. Wiechmann is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, Lymphadenectomy, and Mastectomy. Dr. Wiechmann is board certified in Surgery. Dr. Wiechmann is currently accepting new patients.

Paul L. Baron, MD, is Chief of breast surgery and Director of the breast cancer program at Lenox Hill Hospital. An accomplished breast surgical oncologist, Dr. Baron specializes in high risk patients and oncoplastic surgery. His goals are to oversee the expansion and enhancement of the hospital s breast surgery services and it's multidisciplinary breast cancer program. The Breast Cancer Center of the Northwell Health Cancer Institute, is one of the largest oncology programs in the New York metro area.Throughout his career, Dr. Baron has actively engaged in advancing the field of oncology. He has published more than 120 articles and abstracts on various cancer-related topics and has been invited to speak at more than 60 national conferences. He has received more than $3.3 million in grant funding for medical research from such high-profile sources as the American Cancer Society and the Department of Defense and holds two patents in the area of cancer diagnosis and treatment. He is affiliated with numerous distinguished professional societies, including The American College of Surgeons, The Society of Surgical Oncology and The American Society of Breast Surgeons, where he serves on the board of directors. He also serves on the Board of Directors of the National Accreditation Program for Breast Centers (NAPBC).Dr. Baron earned both his undergraduate and medical degrees from Boston University's six-year medical program. He completed his internship and residency in general surgery at the Medical College of Virginia, where he served as chief surgery resident during his final year. He subsequently pursued a surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center and was honored with the American Cancer Society s Clinical Oncology Fellowship Award for his work. Dr. Baron is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, Lymphadenectomy, and Mastectomy. Dr. Baron is board certified in American Board Of Surgery.

Francisco Esteva is an Oncologist practicing medicine in New York, New York. Dr. Esteva is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Paget Disease of the Breast. Dr. Esteva is board certified in American Board Of Internal Medicine/Medical Oncology.

Bonnie Reichman is an Oncologist practicing medicine in New York, New York. Dr. Reichman is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Intraductal Papilloma, and Inflammatory Breast Cancer. Dr. Reichman is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine/Medical Oncology.

Sheldon Marc Feldman, MD, is Chief, Breast Surgery and Breast Surgical Oncology, Professor, Surgery and Director, Breast Cancer Services at Montefiore Einstein. His clinical focus includes breast cancer, oncoplastic surgery with an emphasis on optimizing breast conservation, nipple-sparing mastectomy, minimally invasive diagnosis and treatment, intraoperative radiation, targeted tumor ablation, lymphedema prevention, and complementary integrative holistic care with an emphasis on physician-patient communication. Dr. Feldman is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Intraductal Papilloma, Breast Cancer, Inflammatory Breast Cancer, Mastectomy, and Lymphadenectomy.

Roxana Kline is a Vascular Surgeon practicing medicine in Hackensack, New Jersey. Dr. Kline is rated as an Advanced provider by MediFind in the treatment of Inflammatory Breast Cancer. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Idiopathic Edema, Familial Pancreatic Cancer, Familial Colorectal Cancer, Bone Marrow Aspiration, and Gastrostomy. Dr. Kline is board certified in American Board Of Surgery.

Robert Tassan is a Hematologist practicing medicine in Hackensack, New Jersey. Dr. Tassan is rated as an Advanced provider by MediFind in the treatment of Inflammatory Breast Cancer. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Adult Immune Thrombocytopenia, Hemangioma Thrombocytopenia Syndrome, and Myelodysplastic Syndrome (MDS). Dr. Tassan is board certified in American Board Of Internal Medicine.

Anoop Wattamwar is an Interventional Radiologist practicing medicine in Hackensack, New Jersey. Dr. Wattamwar is rated as an Advanced provider by MediFind in the treatment of Inflammatory Breast Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Bile Duct Obstruction, Jaundice, T-Cell Lymphoma, Prostatic Artery Embolization, and Gastrostomy. Dr. Wattamwar is board certified in American Board Of Radiology.

Christopher Mcgreevy is a Surgical Oncologist and a General Surgeon practicing medicine in Hackensack, New Jersey. Dr. Mcgreevy is rated as an Advanced provider by MediFind in the treatment of Inflammatory Breast Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Angiosarcoma, Breast Cancer, Intraductal Papilloma, Gastrostomy, and Lymphadenectomy. Dr. Mcgreevy is board certified in American Board Of Surgery.

Marson Davidson is a Surgical Oncologist practicing medicine in Hackensack, New Jersey. Dr. Davidson is rated as an Advanced provider by MediFind in the treatment of Inflammatory Breast Cancer. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, Small Bowel Resection, and Pancreatectomy. Dr. Davidson is board certified in American Board Of Surgery.

Jill Morrison is an Oncologist practicing medicine in Englewood, New Jersey. Dr. Morrison is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Inflammatory Breast Cancer, Breast Cancer, and Angiosarcoma.

Michael Schleider is a Hematologist and an Oncologist practicing medicine in Englewood, New Jersey. Dr. Schleider is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Inflammatory Breast Cancer, Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Bone Marrow Aspiration.

Violet Mcintosh is a General Surgeon practicing medicine in Englewood, New Jersey. Dr. Mcintosh is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Intraductal Papilloma, and Lymphadenectomy.

Gulam Manji, M.D., Ph.D. is an Associate Professor of Medicine at Columbia University Medical Center. Dr. Manji received his M.D. degree from Ross University School of Medicine in 2009 and completed his residency in internal medicine at Albany Medical College. He then completed his fellowship in Hematology/Oncology at NewYork-Presbyterian/Columbia, where his clinical focus was on the treatment of gastrointestinal malignancies, melanoma, and sarcoma under the mentorship of Dr. Gary Schwartz, Chief of Hematology and Oncology.Dr. Manji conducts translational research with the overall goal to developing new treatments for cancer. His focus is in gastrointestinal malignancies, particularly pancreas adenocarcinoma, on which he is conducting preclinical combination immunotherapy studies on genetically engineered mice with pancreas cancer in the Olive laboratory at the Herbert Irving Comprehensive Cancer Center. The combination immunotherapy preclinical proposal received the Young Investigator Award from the American Society of Clinical Oncology-2015. The goal of these preclinical studies is to bring promising new therapies to the clinic in an early phase clinical trials Dr. Manji's research career in identifying new genes and their implication in disease has led to numerous key publications and an issued patent.Dr. Manji cares for patients with gastrointestinal malignancies, with a particular focus on pancreatic and liver cancers, and sarcomas. He is the principal investigator of an investigator-initiated multicenter clinical trial that he wrote with Dr. Gary Schwartz in sarcoma and malignant peripheral nerve sheath tumors and is responsible for clinical trials conducted in liver, bile duct, gallbladder, and pancreas cancers at Columbia University Medical Center. Dr. Manji is rated as an Experienced provider by MediFind in the treatment of Inflammatory Breast Cancer. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Malignant Peripheral Nerve Sheath Tumor, and Familial Pancreatic Cancer. Dr. Manji is board certified in Internal Medicine and Medical Oncology. Dr. Manji is currently accepting new patients.